Patrice Ceballos

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Journal: American journal of hematology

Published: February 03, 2026

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Journal: Bone marrow transplantation

Published: November 30, 2025

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Journal: Bone marrow transplantation

Published: November 19, 2025

The First France-Armenia Hematology Day: Medicine in the Service of Peace, Science and Bone Marrow Transplantation.

The First France-Armenia Hematology Day: Medicine in the Service of Peace, Science and Bone Marrow Transplantation.

Journal: Stem cell reviews and reports

Published: November 05, 2025

Deferasirox 6 months after allo-HSCT in AML/MDS: a prospective propensity-matched study.

Deferasirox 6 months after allo-HSCT in AML/MDS: a prospective propensity-matched study.

Journal: Blood advances

Published: October 27, 2025

Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched Study.

Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched Study.

Journal: Blood advances

Published: October 27, 2025

Allogeneic stem cell transplantation for persons living with HIV (SFGM-TC)

Allogeneic stem cell transplantation for persons living with HIV (SFGM-TC)

Journal: Bulletin du cancer

Published: October 23, 2025

Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Journal: International journal of radiation oncology, biology, physics

Published: June 24, 2025

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 13, 2025

Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party.

Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party.

Journal: Bone marrow transplantation

Published: June 11, 2025

Diagnostic performance of Pneumonia multiplex PCR in critically ill immunocompromised patients.

Diagnostic performance of Pneumonia multiplex PCR in critically ill immunocompromised patients.

Journal: Critical care (London, England)

Published: May 09, 2025

Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.

Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.

Journal: Blood advances

Published: April 30, 2025

Showing 1-12 of 74

Last Updated: 09/26/2026